M. Marcos-Jubilar

发表

[Safety and efficacy of a prothrombin complex concentrate in patients with coagulopathy and hemorrhage].

R. Lecumberri, A. Alfonso, N. Martínez-Calle, 2014, Anales del sistema sanitario de Navarra.

Impact of the mutation profile on thrombotic risk in cancer patients.

R. Lecumberri, J. Páramo, M. Marcos-Jubilar, 2021, Revista clinica espanola.

Thromboprophylaxis in Patients With Cancer and COVID-19

R. Lecumberri, M. Marcos-Jubilar, C. Guillén, 2022, Archivos de Bronconeumología.

Safety and effectiveness of a prothrombin complex concentrate in approved and off‐label indications

J. Paramo, J. A. G. Erce, M. Quintana-Díaz, 2019, Transfusion medicine.

11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value

E. Prieto, J. San-Miguel, L. Sancho, 2022, International journal of molecular sciences.

Post-transplant cyclophosphamide after HLA identical compared to Haploidentical donor transplant in Acute Myeloid Leukemia: a study on behalf of GETH-TC.

C. Solano, J. Sanz, L. Bento, 2022, Transplantation and cellular therapy.

Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives

J. Paramo, R. Lecumberri, M. Marcos-Jubilar, 2023, Journal of clinical medicine.

Association of SDF1 and MMP12 with Atherosclerosis and Inflammation: Clinical and Experimental Study

J. Paramo, A. Fernández-Montero, C. Roncal, 2021, Life.

Analysis of common biomarkers in capillary blood in routine clinical laboratory. Preanalytical and analytical comparison with venous blood

N. Varo, M. Marcos-Jubilar, Débora Martínez-Espartosa, 2023, Diagnosis.

18F-FDG and 11C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers

A. Buck, S. Samnick, J. San-Miguel, 2020, Cancers.

Immunothrombosis: A key mechanism in the COVID-19 pandemic.

M. Marcos-Jubilar, José A Páramo, María Marcos-Jubilar, 2024, Medicina clinica.